Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.09% |
| 2 | Healthcare | 16.64% |
| 3 | Technology | 14.97% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLOX
401
DELISTED
Infoblox Inc
BLOX
| $21M | 0.02% |
1,121,443
-13,614
| -1% | -$236K |
|
|
POT
402
DELISTED
Potash Corp Of Saskatchewan
POT
| $20.9M | 0.02% |
1,284,033
-63,867
| -5% | -$1.07M |
|
403
Sarepta Therapeutics
SRPT
$1.66B
| $19.9M | 0.02% |
+1,045,658
| New | +$19.4M |
|
|
ISBC
404
DELISTED
Investors Bancorp, Inc.
ISBC
| $19.6M | 0.02% |
1,769,835
-52,644
| -3% | -$609K |
|
405
SiteOne Landscape Supply
SITE
$4.43B
| $19.5M | 0.02% |
+574,527
| New | +$16.9M |
|
406
Seres Therapeutics
MCRB
$48.1M
| $19.5M | 0.02% |
33,532
+13,469
| +67% | +$7.9M |
|
|
407
Under Armour
UAA
$3B
| $18.7M | 0.02% |
467,211
-25,898,103
| -98% | -$1.03B |
|
|
MKTO
408
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $18.4M | 0.02% |
528,935
-356,306
| -40% | -$9.86M |
|
|
OKS
409
DELISTED
Oneok Partners LP
OKS
| $18.3M | 0.02% |
456,917
+48,939
| +12% | +$1.79M |
|
|
PKY
410
DELISTED
Parkway, Inc.
PKY
| $18.2M | 0.02% |
1,090,167
-29,851
| -3% | -$494K |
|
|
EPZM
411
DELISTED
Epizyme, Inc
EPZM
| $18.2M | 0.02% |
1,778,675
+12,863
| +0.7% | +$143K |
|
|
PETX
412
DELISTED
Aratana Therapeutics, Inc.
PETX
| $18.1M | 0.02% |
2,859,934
-1,176,191
| -29% | -$7.56M |
|
|
STKL
413
DELISTED
SunOpta
STKL
| $18.1M | 0.02% |
4,312,231
-30,730
| -0.7% | -$142K |
|
414
Celanese
CE
$5.09B
| $17.9M | 0.02% |
274,216
-20,181
| -7% | -$1.4M |
|
415
Bloomin' Brands
BLMN
$680M
| $17.7M | 0.02% |
990,951
+13,337
| +1% | +$247K |
|
|
DBVT
416
DBV Technologies
DBVT
$807M
| $17.4M | 0.02% |
53,459
-642
| -1% | -$208K |
|
|
CIM
417
Chimera Investment
CIM
$1.05B
| $17.3M | 0.02% |
367,025
+4,942
| +1% | +$218K |
|
418
Cheniere Energy
LNG
$56.5B
| $17.2M | 0.02% |
+457,238
| New | +$16.1M |
|
419
Neurocrine Biosciences
NBIX
$17.7B
| $16.8M | 0.02% |
369,812
-428
| -0.1% | -$19.7K |
|
|
ALR
420
CALL
DELISTED
Alere Inc
ALR
| $16.7M | 0.02% |
+400,000
| New | +$17.4M |
|
|
DTEA
421
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $16.6M | 0.02% |
1,220,836
+326,763
| +37% | +$3.88M |
|
422
Graco
GGG
$12.9B
| $16.6M | 0.02% |
630,570
+259,947
| +70% | +$6.98M |
|
|
DM
423
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $16.4M | 0.02% |
583,939
-272,358
| -32% | -$8.12M |
|
|
TIVO
424
DELISTED
Tivo Inc
TIVO
| $16.4M | 0.02% |
1,046,492
-1,310,849
| -56% | -$22M |
|
|
YDKN
425
DELISTED
Yadkin Financial Corporation
YDKN
| $16.3M | 0.02% |
+651,344
| New | +$16.3M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $4.67B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.